Jens Y Humrich

6PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCardiology (incl. cardiovascular diseases)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2026
Interleukin-2 Deprived State of Regulatory T cells and Their Recovery by Low-Dose Interleukin-2 in Patients With Inflammatory Myopathies.

Justus Ohmes, Luisa R Monne, Sara Comdühr

|Jun 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases.

El-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke

|Nov 09, 2023
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.

Felix S Müller, Zouhair Aherrahrou, Hanna Grasshoff

|Aug 16, 2022
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial.

Jens Y Humrich, Patrice Cacoub, Michelle Rosenzwajg

|Mar 10, 2022
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.

Otavio Cabral-Marques, Gilad Halpert, Lena F Schimke

|Oct 17, 2019
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.

Angelika Rose, Caroline von Spee-Mayer, Lutz Kloke

Pageof 1

Frequent Collaborators

3 joint publications

Gabriela Riemekasten

2 joint publications

Hanna Grasshoff

1 joint publications

Otavio Cabral-Marques

1 joint publications

Lena F Schimke